fluoxetine has been researched along with Neurotic Disorders in 6 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Psychiatrists were much more likely than family practitioners to prescribe fluoxetine for obsessive-compulsive disorder (OCD), and more likely to prescribe for a patient with a history of substance abuse or seizure disorder." | 3.68 | Prescribing attitudes of different physician groups regarding fluoxetine. ( DeVane, CL; Levin, GM, 1993) |
| "Although selective serotonin reuptake inhibitors (SSRI) are generally effective in reducing impulsive aggression in individuals with intermittent explosive disorder, a large proportion of intermittent explosive disorder patients fail to achieve full remission despite adequate dosage and duration of treatment." | 2.76 | Personality predictors of antiaggressive response to fluoxetine: inverse association with neuroticism and harm avoidance. ( Coccaro, EF; Lee, R; Phan, KL, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Phan, KL | 1 |
| Lee, R | 1 |
| Coccaro, EF | 1 |
| Talarowska, M | 1 |
| Zboralski, K | 1 |
| Chamielec, M | 1 |
| Gałecki, P | 1 |
| Enns, MW | 1 |
| Cox, BJ | 1 |
| Levitt, AJ | 1 |
| Levitan, RD | 1 |
| Morehouse, R | 1 |
| Michalak, EE | 1 |
| Lam, RW | 1 |
| Barondes, SH | 1 |
| Levin, GM | 1 |
| DeVane, CL | 1 |
| Kudriashova, MF | 1 |
| Andreev, BV | 1 |
2 trials available for fluoxetine and Neurotic Disorders
| Article | Year |
|---|---|
Personality predictors of antiaggressive response to fluoxetine: inverse association with neuroticism and harm avoidance.
Topics: Adult; Aggression; Avoidance Learning; Fluoxetine; Harm Reduction; Humans; Male; Middle Aged; Neurot | 2011 |
Personality and seasonal affective disorder: results from the CAN-SAD study.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Diagnosis, Differential; Femal | 2006 |
4 other studies available for fluoxetine and Neurotic Disorders
| Article | Year |
|---|---|
The MMPI-2 neurotic triad subscales and depression levels after pharmacological treatment in patients with depressive disorders - clinical study.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Hypochond | 2011 |
Thinking about Prozac.
Topics: Depressive Disorder; Fluoxetine; Humans; Neurotic Disorders; Psychiatry; Psychopharmacology | 1994 |
Prescribing attitudes of different physician groups regarding fluoxetine.
Topics: Depressive Disorder; Drug Utilization; Female; Florida; Fluoxetine; Health Knowledge, Attitudes, Pra | 1993 |
[Neuropharmacological analysis of participation of the serotoninergic system in hyperalgesia in neurotized rats].
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Buspirone; Fluoxetine; Hyperalgesia; Male; Mian | 2000 |